+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Cell Reprogramming - Global Strategic Business Report - Product Thumbnail Image

Cell Reprogramming - Global Strategic Business Report

  • Report
  • April 2026
  • 369 Pages
  • Global
From
From
From
Musculoskeletal Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Musculoskeletal Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 300 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 300 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2026 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2026

  • Report
  • January 2026
  • 550 Pages
  • Global
From
From
Colorectal Cancer Drugs Market Report 2026 - Product Thumbnail Image

Colorectal Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Collaboration Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 850 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 1200 Pages
  • Global
From
Loading Indicator